2025

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

13 minutes ago

Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8…

5 hours ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…

8 hours ago

VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI

ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1® Team's Lando Norris celebrated his first ever Drivers'…

8 hours ago

Mantle “2025 RWApped”: A Year of Unstoppable MoMNTum and Global RWA Expansion

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- In 2025, Mantle entered a new phase of its evolution. What began as a high-performance…

9 hours ago

Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025

December 08, 2025 07:00 ET  | Source: Mercury Systems Inc ANDOVER, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Mercury Systems,…

11 hours ago

Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up

Some of the biggest names in phygital sports and esports from around the world will head to Abu Dhabi for…

12 hours ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

December 07, 2025 16:00 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…

1 day ago

14th Olympic Summit on 11 December 2025 Information for the media

05 December 2025 - The International Olympic Committee (IOC) will host the 14th Olympic Summit on 11 December 2025 in Lausanne,…

3 days ago

ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

December 05, 2025 20:00 ET  | Source: ORIC Pharmaceuticals Highly differentiated 1L preliminary systemic activity of 67% ORR and 100%…

3 days ago